查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1654348

全球戊型肝炎診斷檢測市場：市場規模、佔有率、趨勢分析（按類型、最終用途和地區）、細分市場預測（2025-2030 年）

Hepatitis E Diagnostic Tests Market Size, Share & Trends Analysis Report By Type (ELISA HEV IgM Test, Rapid Diagnostics Test), By End-use (Hospitals, Blood Banks), By Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 100 Pages | 商品交期: 2-10個工作天內

價格

戊型肝炎診斷檢測市場趨勢：

2024 年全球戊型肝炎診斷檢測市場規模價值 5,710 萬美元，預估 2025 年至 2030 年期間複合年成長率為 4.8%。

戊型肝炎在全球的蔓延，特別是在發展中地區，正在推動對診斷測試的需求。隨著公共衛生宣傳活動和資訊獲取管道的改善，人們對戊型肝炎的認知不斷提高，越來越多的人尋求早期發現和治療。這種日益增強的認知推動了診斷測試的採用，從而促進了市場的擴大。此外，對疫情預防和醫療保健基礎設施改善的日益關注以及檢測技術的不斷進步也刺激了戊型肝炎診斷檢測市場的成長。

此外，先進的分子技術、快速檢測平台和照護現場（POC）解決方案等診斷技術的創新將顯著提高戊型肝炎的檢測能力。偏遠和資源貧乏地區對快速獲得結果的需求增加了對 POC 診斷的偏好，從而進一步推動了市場成長。由於醫療保健系統優先考慮早期診斷和及時干預，戊型肝炎診斷檢測市場預計將在未來幾年大幅擴張。

目錄

第1章 分析方法及範圍

第 2 章執行摘要

3. 戊型肝炎診斷檢測市場：促進因素、趨勢與範圍

  • 市場聯動展望
  • 市場動態
    • 市場促進因素分析
    • 市場限制分析
  • 商業環境分析
    • 產業分析：波特五力分析
    • PESTEL 分析

第 4 章 戊型肝炎診斷檢測市場：按類型進行的業務分析

  • 按類型分類的市場佔有率（2024 年和 2030 年）
  • 按類型分類的儀表板
  • 按類型分類的市場規模預測及趨勢分析（2018-2030）
  • ELISA HEV IgM 檢測
  • ELISA HEV IgG 檢測
  • 快速診斷測試
  • 聚合酵素鏈鎖反應（PCR）

5. 戊型肝炎診斷檢測市場：依最終用途進行的業務分析

  • 按最終用途分類的市場佔有率（2024 年和 2030 年）
  • 最終用途儀表板
  • 按最終用途分類的市場規模預測和趨勢分析（2018-2030 年）
  • 醫院
  • 診斷實驗室
  • 血庫
  • 其他

6. 戊型肝炎診斷檢測市場：區域估計與趨勢分析

  • 各地區市場佔有率（2024 年及 2030 年）
  • 市場儀表板：按地區
  • 市場規模預測及趨勢分析（2018-2030年）
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 丹麥
    • 瑞典
    • 挪威
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 韓國
    • 泰國
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第7章 競爭格局

  • 參與企業概況
  • 企業市場分析
  • 公司分類
  • 戰略地圖
  • 公司簡介/上市公司
    • Wantai BioPharm
    • MP Biomedicals LLP
    • PerkinElmer, Inc
    • Dia.Pro Diagnostic Bioprobes srl
    • ELITechGroup
    • Primerdesign Ltd
    • F. Hoffmann-La Roche Ltd
    • Mikrogen GmbH
    • Altona Diagnostics
    • Fortress Diagnostics
Product Code: GVR-4-68040-373-5

Hepatitis E Diagnostic Tests Market Trends:

The global hepatitis E diagnostic tests market size was valued at USD 57.1 million in 2024 and is projected to witness a CAGR of 4.8% from 2025 to 2030. The growing prevalence of Hepatitis E globally, especially in developing regions, significantly drives the demand for diagnostic tests. As the awareness surrounding Hepatitis E increases due to public health campaigns and improved access to information, more individuals are seeking early detection and treatment. This heightened awareness is boosting the adoption of diagnostic tests, contributing to the market's expansion. Additionally, the emphasis on preventing outbreaks and improving healthcare infrastructure further stimulates the growth of the Hepatitis E diagnostic test market, with continued advancements in testing technology.

In addition, innovations in diagnostic technologies, such as advanced molecular techniques, rapid testing platforms, and point-of-care (POC) solutions, significantly enhance the detection of hepatitis E. These advancements offer faster, more accurate, cost-effective diagnostics, which are expected to increase market demand. The surge in preference for POC diagnostics, driven by the need for quick results in remote or resource-limited areas, further boosts market growth. As healthcare systems prioritize early diagnosis and timely interventions, the hepatitis E diagnostic tests market is poised for substantial expansion in the years ahead.

Global Hepatitis E Diagnostic Tests Market Report Segmentation

This report forecasts revenue and volume growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For the purpose of this study, Grand View Research has segmented the global hepatitis E diagnostic tests market report based on type, end-use, and region:

  • Type Outlook (Revenue, USD Million, 2018 - 2030)
  • ELISA HEV IgM Tests
  • ELISA HEV IgG Tests
  • Rapid Diagnostics Tests
  • Polymerase Chain Reaction (PCR)
  • End-use Outlook (Revenue, USD Million, 2018 - 2030)
  • Hospitals
  • Diagnostics Laboratories
  • Blood Banks
  • Others
  • Regional Outlook (Revenue, USD Million, 2018 - 2030)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Thailand
  • Latin America
    • Brazil
    • Argentina
  • Middle East and Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Type
    • 1.2.2. End Use
  • 1.3. Estimates and Forecast Timeline
  • 1.4. Research Methodology
  • 1.5. Information Procurement
    • 1.5.1. Purchased Database
    • 1.5.2. GVR's Internal Database
    • 1.5.3. Secondary Sources
    • 1.5.4. Primary Research
  • 1.6. Information Analysis
    • 1.6.1. Data Analysis Models
  • 1.7. Market Formulation & Data Visualization
  • 1.8. Model Details
    • 1.8.1. Commodity Flow Analysis
  • 1.9. List of Secondary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Hepatitis E Diagnostic Tests Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
    • 3.2.2. Market Restraint Analysis
  • 3.3. Business Environment Analysis
    • 3.3.1. Industry Analysis - Porter's Five Forces Analysis
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTLE Analysis

Chapter 4. Hepatitis E Diagnostic Tests Market: Type Business Analysis

  • 4.1. Type Market Share, 2024 & 2030
  • 4.2. Type Segment Dashboard
  • 4.3. Market Size & Forecasts and Trend Analysis, by Type, 2018 to 2030 (USD Million)
  • 4.4. ELISA HEV IgM Tests
    • 4.4.1. ELISA HEV IgM Tests Market, 2018 - 2030 (USD Million)
  • 4.5. ELISA HEV IgG Tests
    • 4.5.1. ELISA HEV IgG Tests Market, 2018 - 2030 (USD Million)
  • 4.6. Rapid Diagnostics Tests
    • 4.6.1. Rapid Diagnostics Tests Market, 2018 - 2030 (USD Million)
  • 4.7. Polymerase Chain Reaction (PCR)
    • 4.7.1. Polymerase Chain Reaction (PCR) Market, 2018 - 2030 (USD Million)

Chapter 5. Hepatitis E Diagnostic Tests Market: End Use Business Analysis

  • 5.1. End Use Market Share, 2024 & 2030
  • 5.2. End Use Segment Dashboard
  • 5.3. Market Size & Forecasts and Trend Analysis, by End Use, 2018 to 2030 (USD Million)
  • 5.4. Hospitals
    • 5.4.1. Hospitals market, 2018 - 2030 (USD Million)
  • 5.5. Diagnostics Laboratories
    • 5.5.1. Diagnostics Laboratories Market, 2018 - 2030 (USD Million)
  • 5.6. Blood Banks
    • 5.6.1. Blood Banks Market, 2018 - 2030 (USD Million)
  • 5.7. Others
    • 5.7.1. Others Market, 2018 - 2030 (USD Million)

Chapter 6. Hepatitis E Diagnostic Tests Market: Regional Estimates & Trend Analysis

  • 6.1. Regional Market Share Analysis, 2024 & 2030
  • 6.2. Regional Market Dashboard
  • 6.3. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
  • 6.4. North America
    • 6.4.1. North America Hepatitis E Diagnostic Tests Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.2. U.S.
      • 6.4.2.1. Key Country Dynamics
      • 6.4.2.2. Regulatory Framework
      • 6.4.2.3. Competitive Insights
      • 6.4.2.4. U.S. Hepatitis E Diagnostic Tests Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.3. Canada
      • 6.4.3.1. Key Country Dynamics
      • 6.4.3.2. Regulatory Framework
      • 6.4.3.3. Competitive Insights
      • 6.4.3.4. Canada Hepatitis E Diagnostic Tests Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.4. Mexico
      • 6.4.4.1. Key Country Dynamics
      • 6.4.4.2. Regulatory Framework
      • 6.4.4.3. Competitive Insights
      • 6.4.4.4. Mexico Hepatitis E Diagnostic Tests Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5. Europe
    • 6.5.1. Europe Hepatitis E Diagnostic Tests Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.2. UK
      • 6.5.2.1. Key Country Dynamics
      • 6.5.2.2. Regulatory Framework
      • 6.5.2.3. Competitive Insights
      • 6.5.2.4. UK Hepatitis E Diagnostic Tests Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.3. Germany
      • 6.5.3.1. Key Country Dynamics
      • 6.5.3.2. Regulatory Framework
      • 6.5.3.3. Competitive Insights
      • 6.5.3.4. Germany Hepatitis E Diagnostic Tests Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.4. France
      • 6.5.4.1. Key Country Dynamics
      • 6.5.4.2. Regulatory Framework
      • 6.5.4.3. Competitive Insights
      • 6.5.4.4. France Hepatitis E Diagnostic Tests Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.5. Italy
      • 6.5.5.1. Key Country Dynamics
      • 6.5.5.2. Regulatory Framework
      • 6.5.5.3. Competitive Insights
      • 6.5.5.4. Italy Hepatitis E Diagnostic Tests Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.6. Spain
      • 6.5.6.1. Key Country Dynamics
      • 6.5.6.2. Regulatory Framework
      • 6.5.6.3. Competitive Insights
      • 6.5.6.4. Spain Hepatitis E Diagnostic Tests Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.7. Denmark
      • 6.5.7.1. Key Country Dynamics
      • 6.5.7.2. Regulatory Framework
      • 6.5.7.3. Competitive Insights
      • 6.5.7.4. Denmark Hepatitis E Diagnostic Tests Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.8. Sweden
      • 6.5.8.1. Key Country Dynamics
      • 6.5.8.2. Regulatory Framework
      • 6.5.8.3. Competitive Insights
      • 6.5.8.4. Norway Hepatitis E Diagnostic Tests Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.9. Norway
      • 6.5.9.1. Key Country Dynamics
      • 6.5.9.2. Regulatory Framework
      • 6.5.9.3. Competitive Insights
      • 6.5.9.4. Sweden Hepatitis E Diagnostic Tests Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6. Asia Pacific
    • 6.6.1. Asia Pacific Hepatitis E Diagnostic Tests Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.2. Japan
      • 6.6.2.1. Key Country Dynamics
      • 6.6.2.2. Regulatory Framework
      • 6.6.2.3. Competitive Insights
      • 6.6.2.4. Japan Hepatitis E Diagnostic Tests Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.3. China
      • 6.6.3.1. Key Country Dynamics
      • 6.6.3.2. Regulatory Framework
      • 6.6.3.3. Competitive Insights
      • 6.6.3.4. China Hepatitis E Diagnostic Tests Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.4. India
      • 6.6.4.1. Key Country Dynamics
      • 6.6.4.2. Regulatory Framework
      • 6.6.4.3. Competitive Insights
      • 6.6.4.4. India Hepatitis E Diagnostic Tests Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.5. Australia
      • 6.6.5.1. Key Country Dynamics
      • 6.6.5.2. Regulatory Framework
      • 6.6.5.3. Competitive Insights
      • 6.6.5.4. South Korea Hepatitis E Diagnostic Tests Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.6. South Korea
      • 6.6.6.1. Key Country Dynamics
      • 6.6.6.2. Regulatory Framework
      • 6.6.6.3. Competitive Insights
      • 6.6.6.4. Australia Hepatitis E Diagnostic Tests Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.7. Thailand
      • 6.6.7.1. Key Country Dynamics
      • 6.6.7.2. Regulatory Framework
      • 6.6.7.3. Competitive Insights
      • 6.6.7.4. Thailand Hepatitis E Diagnostic Tests Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.7. Latin America
    • 6.7.1. Latin America Hepatitis E Diagnostic Tests Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.7.2. Brazil
      • 6.7.2.1. Key Country Dynamics
      • 6.7.2.2. Regulatory Framework
      • 6.7.2.3. Competitive Insights
      • 6.7.2.4. Brazil Hepatitis E Diagnostic Tests Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.7.3. Argentina
      • 6.7.3.1. Key Country Dynamics
      • 6.7.3.2. Regulatory Framework
      • 6.7.3.3. Competitive Insights
      • 6.7.3.4. Argentina Hepatitis E Diagnostic Tests Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.8. MEA
    • 6.8.1. MEA Hepatitis E Diagnostic Tests Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.8.2. South Africa
      • 6.8.2.1. Key Country Dynamics
      • 6.8.2.2. Regulatory Framework
      • 6.8.2.3. Competitive Insights
      • 6.8.2.4. South Africa Hepatitis E Diagnostic Tests Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.8.3. Saudi Arabia
      • 6.8.3.1. Key Country Dynamics
      • 6.8.3.2. Regulatory Framework
      • 6.8.3.3. Competitive Insights
      • 6.8.3.4. Saudi Arabia Hepatitis E Diagnostic Tests Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.8.4. UAE
      • 6.8.4.1. Key Country Dynamics
      • 6.8.4.2. Regulatory Framework
      • 6.8.4.3. Competitive Insights
      • 6.8.4.4. UAE Hepatitis E Diagnostic Tests Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.8.5. Kuwait
      • 6.8.5.1. Key Country Dynamics
      • 6.8.5.2. Regulatory Framework
      • 6.8.5.3. Competitive Insights
      • 6.8.5.4. Kuwait Hepatitis E Diagnostic Tests Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Participant Overview
  • 7.2. Company Market Position Analysis
  • 7.3. Company Categorization
  • 7.4. Strategy Mapping
  • 7.5. Company Profiles/Listing
    • 7.5.1. Wantai BioPharm
      • 7.5.1.1. Overview
      • 7.5.1.2. Financial Performance
      • 7.5.1.3. Product Benchmarking
      • 7.5.1.4. Strategic Initiatives
    • 7.5.2. MP Biomedicals LLP
      • 7.5.2.1. Overview
      • 7.5.2.2. Financial Performance
      • 7.5.2.3. Product Benchmarking
      • 7.5.2.4. Strategic Initiatives
    • 7.5.3. PerkinElmer, Inc
      • 7.5.3.1. Overview
      • 7.5.3.2. Financial Performance
      • 7.5.3.3. Product Benchmarking
      • 7.5.3.4. Strategic Initiatives
    • 7.5.4. Dia.Pro Diagnostic Bioprobes srl
      • 7.5.4.1. Overview
      • 7.5.4.2. Financial Performance
      • 7.5.4.3. Product Benchmarking
      • 7.5.4.4. Strategic Initiatives
    • 7.5.5. ELITechGroup
      • 7.5.5.1. Overview
      • 7.5.5.2. Financial Performance
      • 7.5.5.3. Product Benchmarking
      • 7.5.5.4. Strategic Initiatives
    • 7.5.6. Primerdesign Ltd
      • 7.5.6.1. Overview
      • 7.5.6.2. Financial Performance
      • 7.5.6.3. Product Benchmarking
      • 7.5.6.4. Strategic Initiatives
    • 7.5.7. F. Hoffmann-La Roche Ltd
      • 7.5.7.1. Overview
      • 7.5.7.2. Financial Performance
      • 7.5.7.3. Product Benchmarking
      • 7.5.7.4. Strategic Initiatives
    • 7.5.8. Mikrogen GmbH
      • 7.5.8.1. Overview
      • 7.5.8.2. Financial Performance
      • 7.5.8.3. Product Benchmarking
      • 7.5.8.4. Strategic Initiatives
    • 7.5.9. Altona Diagnostics
      • 7.5.9.1. Overview
      • 7.5.9.2. Financial Performance
      • 7.5.9.3. Product Benchmarking
      • 7.5.9.4. Strategic Initiatives
    • 7.5.10. Fortress Diagnostics
      • 7.5.10.1. Overview
      • 7.5.10.2. Financial Performance
      • 7.5.10.3. Product Benchmarking
      • 7.5.10.4. Strategic Initiatives

List of Tables

  • Table 1. List of secondary sources
  • Table 2. List of abbreviations
  • Table 3. Global hepatitis E diagnostic tests market, by region, 2018 - 2030 (USD Million)
  • Table 4. Global hepatitis E diagnostic tests market, by type, 2018 - 2030 (USD Million)
  • Table 5. Global hepatitis E diagnostic tests market, by end use, 2018 - 2030 (USD Million)
  • Table 6. North America hepatitis E diagnostic tests market, by country, 2018 - 2030 (USD Million)
  • Table 7. North America hepatitis E diagnostic tests market, by type, 2018 - 2030 (USD Million)
  • Table 8. North America hepatitis E diagnostic tests market, by end use, 2018 - 2030 (USD Million)
  • Table 9. U.S. hepatitis E diagnostic tests market, by type, 2018 - 2030 (USD Million)
  • Table 10. U.S. hepatitis E diagnostic tests market, by end use, 2018 - 2030 (USD Million)
  • Table 11. Canada hepatitis E diagnostic tests market, by type, 2018 - 2030 (USD Million)
  • Table 12. Canada hepatitis E diagnostic tests market, by end use, 2018 - 2030 (USD Million)
  • Table 13. Mexico hepatitis E diagnostic tests market, by type, 2018 - 2030 (USD Million)
  • Table 14. Mexico hepatitis E diagnostic tests market, by end use, 2018 - 2030 (USD Million)
  • Table 15. Europe hepatitis E diagnostic tests market, by country, 2018 - 2030 (USD Million)
  • Table 16. Europe hepatitis E diagnostic tests market, by type, 2018 - 2030 (USD Million)
  • Table 17. Europe hepatitis E diagnostic tests market, by end use, 2018 - 2030 (USD Million)
  • Table 18. UK hepatitis E diagnostic tests market, by type, 2018 - 2030 (USD Million)
  • Table 19. UK hepatitis E diagnostic tests market, by end use, 2018 - 2030 (USD Million)
  • Table 20. Germany hepatitis E diagnostic tests market, by type, 2018 - 2030 (USD Million)
  • Table 21. Germany hepatitis E diagnostic tests market, by end use, 2018 - 2030 (USD Million)
  • Table 22. France hepatitis E diagnostic tests market, by type, 2018 - 2030 (USD Million)
  • Table 23. France hepatitis E diagnostic tests market, by end use, 2018 - 2030 (USD Million)
  • Table 24. Italy hepatitis E diagnostic tests market, by type, 2018 - 2030 (USD Million)
  • Table 25. Italy hepatitis E diagnostic tests market, by end use, 2018 - 2030 (USD Million)
  • Table 26. Spain hepatitis E diagnostic tests market, by type, 2018 - 2030 (USD Million)
  • Table 27. Spain hepatitis E diagnostic tests market, by end use, 2018 - 2030 (USD Million)
  • Table 28. Denmark hepatitis E diagnostic tests market, by type, 2018 - 2030 (USD Million)
  • Table 29. Denmark hepatitis E diagnostic tests market, by end use, 2018 - 2030 (USD Million)
  • Table 30. Sweden hepatitis E diagnostic tests market, by type, 2018 - 2030 (USD Million)
  • Table 31. Sweden hepatitis E diagnostic tests market, by end use, 2018 - 2030 (USD Million)
  • Table 32. Norway hepatitis E diagnostic tests market, by type, 2018 - 2030 (USD Million)
  • Table 33. Norway hepatitis E diagnostic tests market, by end use, 2018 - 2030 (USD Million)
  • Table 34. Asia Pacific hepatitis E diagnostic tests market, by country, 2018 - 2030 (USD Million)
  • Table 35. Asia Pacific hepatitis E diagnostic tests market, by type, 2018 - 2030 (USD Million)
  • Table 36. Asia Pacific hepatitis E diagnostic tests market, by end use, 2018 - 2030 (USD Million)
  • Table 37. Japan hepatitis E diagnostic tests market, by type, 2018 - 2030 (USD Million)
  • Table 38. Japan hepatitis E diagnostic tests market, by end use, 2018 - 2030 (USD Million)
  • Table 39. China hepatitis E diagnostic tests market, by type, 2018 - 2030 (USD Million)
  • Table 40. China hepatitis E diagnostic tests market, by end use, 2018 - 2030 (USD Million)
  • Table 41. India hepatitis E diagnostic tests market, by type, 2018 - 2030 (USD Million)
  • Table 42. India hepatitis E diagnostic tests market, by end use, 2018 - 2030 (USD Million)
  • Table 43. Australia hepatitis E diagnostic tests market, by type, 2018 - 2030 (USD Million)
  • Table 44. Australia hepatitis E diagnostic tests market, by end use, 2018 - 2030 (USD Million)
  • Table 45. South Korea hepatitis E diagnostic tests market, by type, 2018 - 2030 (USD Million)
  • Table 46. South Korea hepatitis E diagnostic tests market, by end use, 2018 - 2030 (USD Million)
  • Table 47. Thailand hepatitis E diagnostic tests market, by type, 2018 - 2030 (USD Million)
  • Table 48. Thailand hepatitis E diagnostic tests market, by end use, 2018 - 2030 (USD Million)
  • Table 49. Latin America hepatitis E diagnostic tests market, by country, 2018 - 2030 (USD Million)
  • Table 50. Latin America hepatitis E diagnostic tests market, by type, 2018 - 2030 (USD Million)
  • Table 51. Latin America hepatitis E diagnostic tests market, by end use, 2018 - 2030 (USD Million)
  • Table 52. Brazil hepatitis E diagnostic tests market, by type, 2018 - 2030 (USD Million)
  • Table 53. Brazil hepatitis E diagnostic tests market, by end use, 2018 - 2030 (USD Million)
  • Table 54. Argentina hepatitis E diagnostic tests market, by type, 2018 - 2030 (USD Million)
  • Table 55. Argentina hepatitis E diagnostic tests market, by end use, 2018 - 2030 (USD Million)
  • Table 56. Middle East & Africa hepatitis E diagnostic tests market, by country, 2018 - 2030 (USD Million)
  • Table 57. Middle East & Africa hepatitis E diagnostic tests market, by type, 2018 - 2030 (USD Million)
  • Table 58. Middle East & Africa hepatitis E diagnostic tests market, by end use, 2018 - 2030 (USD Million)
  • Table 59. South Africa hepatitis E diagnostic tests market, by type, 2018 - 2030 (USD Million)
  • Table 60. South Africa hepatitis E diagnostic tests market, by end use, 2018 - 2030 (USD Million)
  • Table 61. Saudi Arabia hepatitis E diagnostic tests market, by type, 2018 - 2030 (USD Million)
  • Table 62. Saudi Arabia hepatitis E diagnostic tests market, by end use, 2018 - 2030 (USD Million)
  • Table 63. UAE hepatitis E diagnostic tests market, by type, 2018 - 2030 (USD Million)
  • Table 64. UAE hepatitis E diagnostic tests market, by end use, 2018 - 2030 (USD Million)
  • Table 65. Kuwait hepatitis E diagnostic tests market, by type, 2018 - 2030 (USD Million)
  • Table 66. Kuwait hepatitis E diagnostic tests market, by end use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Hepatitis E diagnostic tests market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Data triangulation techniques
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value-chain-based sizing & forecasting
  • Fig. 7 Market formulation & validation
  • Fig. 8 Market snapshot
  • Fig. 9 Type and end use outlook (USD Million)
  • Fig. 11 Competitive landscape
  • Fig. 12 Hepatitis E diagnostic tests market dynamics
  • Fig. 13 Hepatitis E diagnostic tests market: Porter's five forces analysis
  • Fig. 14 Hepatitis E diagnostic tests market: PESTLE analysis
  • Fig. 15 Hepatitis E diagnostic tests market: Type segment dashboard
  • Fig. 16 Hepatitis E diagnostic tests market: Type market share analysis, 2024 & 2030
  • Fig. 17 ELISA HEV IgM tests market, 2018 - 2030 (USD Million)
  • Fig. 18 ELISA HEV IgG tests market, 2018 - 2030 (USD Million)
  • Fig. 19 Rapid diagnostics tests market, 2018 - 2030 (USD Million)
  • Fig. 20 Polymerase Chain Reaction (PCR) market, 2018 - 2030 (USD Million)
  • Fig. 21 Hepatitis E diagnostic tests market: End use segment dashboard
  • Fig. 22 Hepatitis E diagnostic tests market: End use market share analysis, 2024 & 2030
  • Fig. 23 Hospitals market, 2018 - 2030 (USD Million)
  • Fig. 24 Diagnostics laboratories market, 2018 - 2030 (USD Million)
  • Fig. 25 Blood banks market, 2018 - 2030 (USD Million)
  • Fig. 26 Others market, 2018 - 2030 (USD Million)
  • Fig. 27 Hepatitis E diagnostic tests market revenue, by region
  • Fig. 28 Regional marketplace: Key takeaways
  • Fig. 29 Regional marketplace: Key takeaways
  • Fig. 30 North America hepatitis E diagnostic tests market, 2018 - 2030 (USD Million)
  • Fig. 31 U.S. country dynamics
  • Fig. 32 U.S. hepatitis E diagnostic tests market, 2018 - 2030 (USD Million)
  • Fig. 33 Canada country dynamics
  • Fig. 34 Canada hepatitis E diagnostic tests market, 2018 - 2030 (USD Million)
  • Fig. 35 Mexico country dynamics
  • Fig. 36 Mexico hepatitis E diagnostic tests market, 2018 - 2030 (USD Million)
  • Fig. 37 Europe hepatitis E diagnostic tests market, 2018 - 2030 (USD Million)
  • Fig. 38 UK country dynamics
  • Fig. 39 UK hepatitis E diagnostic tests market, 2018 - 2030 (USD Million)
  • Fig. 40 Germany country dynamics
  • Fig. 41 Germany hepatitis E diagnostic tests market, 2018 - 2030 (USD Million)
  • Fig. 42 France country dynamics
  • Fig. 43 France hepatitis E diagnostic tests market, 2018 - 2030 (USD Million)
  • Fig. 44 Italy country dynamics
  • Fig. 45 Italy hepatitis E diagnostic tests market, 2018 - 2030 (USD Million)
  • Fig. 46 Spain country dynamics
  • Fig. 47 Spain hepatitis E diagnostic tests market, 2018 - 2030 (USD Million)
  • Fig. 48 Denmark country dynamics
  • Fig. 49 Denmark hepatitis E diagnostic tests market, 2018 - 2030 (USD Million)
  • Fig. 50 Sweden country dynamics
  • Fig. 51 Sweden hepatitis E diagnostic tests market, 2018 - 2030 (USD Million)
  • Fig. 52 Norway country dynamics
  • Fig. 53 Norway hepatitis E diagnostic tests market, 2018 - 2030 (USD Million)
  • Fig. 54 Asia Pacific hepatitis E diagnostic tests market, 2018 - 2030 (USD Million)
  • Fig. 55 Japan country dynamics
  • Fig. 56 Japan hepatitis E diagnostic tests market, 2018 - 2030 (USD Million)
  • Fig. 57 China country dynamics
  • Fig. 58 China hepatitis E diagnostic tests market, 2018 - 2030 (USD Million)
  • Fig. 59 India country dynamics
  • Fig. 60 India hepatitis E diagnostic tests market, 2018 - 2030 (USD Million)
  • Fig. 61 Australia country dynamics
  • Fig. 62 Australia hepatitis E diagnostic tests market, 2018 - 2030 (USD Million)
  • Fig. 63 South Korea country dynamics
  • Fig. 64 South Korea hepatitis E diagnostic tests market, 2018 - 2030 (USD Million)
  • Fig. 65 Thailand country dynamics
  • Fig. 66 Thailand hepatitis E diagnostic tests market, 2018 - 2030 (USD Million)
  • Fig. 67 Latin America hepatitis E diagnostic tests market, 2018 - 2030 (USD Million)
  • Fig. 68 Brazil country dynamics
  • Fig. 69 Brazil hepatitis E diagnostic tests market, 2018 - 2030 (USD Million)
  • Fig. 70 Argentina country dynamics
  • Fig. 71 Argentina hepatitis E diagnostic tests market, 2018 - 2030 (USD Million)
  • Fig. 72 MEA hepatitis E diagnostic tests market, 2018 - 2030 (USD Million)
  • Fig. 73 South Africa country dynamics
  • Fig. 74 South Africa hepatitis E diagnostic tests market, 2018 - 2030 (USD Million)
  • Fig. 75 Saudi Arabia country dynamics
  • Fig. 76 Saudi Arabia hepatitis E diagnostic tests market, 2018 - 2030 (USD Million)
  • Fig. 77 UAE country dynamics
  • Fig. 78 UAE hepatitis E diagnostic tests market, 2018 - 2030 (USD Million)
  • Fig. 79 Kuwait Key country dynamicss
  • Fig. 80 Kuwait hepatitis E diagnostic tests market, 2018 - 2030 (USD Million)
  • Fig. 81 Company categorization
  • Fig. 82 Company market position analysis
  • Fig. 83 Strategic framework